Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Down – Here’s What Happened

Bayer Aktiengesellschaft (OTCMKTS:BAYRY)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $13.97, but opened at $13.58. Bayer Aktiengesellschaft shares last traded at $13.61, with a volume of 43,051 shares changing hands.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Zacks Research upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. DZ Bank upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Deutsche Bank Aktiengesellschaft upgraded Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note on Thursday, July 2nd. Finally, Jefferies Financial Group raised Bayer Aktiengesellschaft to a “hold” rating in a report on Friday, May 29th. Two investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Performance

The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.70 and a current ratio of 1.05. The firm has a market cap of $53.47 billion, a P/E ratio of -21.26, a P/E/G ratio of 4.46 and a beta of 0.55. The company’s 50 day moving average is $11.67 and its 200 day moving average is $11.83.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its earnings results on Tuesday, May 12th. The company reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.64 by $0.15. The firm had revenue of $15.73 billion for the quarter, compared to analysts’ expectations of $15.77 billion. Bayer Aktiengesellschaft had a negative net margin of 4.75% and a positive return on equity of 17.61%. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. As a group, equities analysts predict that Bayer Aktiengesellschaft will post 1.27 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a global life sciences company headquartered in Leverkusen, Germany, with a history dating back to 1863. The company operates across three principal business areas—Pharmaceuticals, Consumer Health and Crop Science—serving customers and markets worldwide. Bayer develops, manufactures and markets prescription medicines, over-the-counter healthcare products and agricultural solutions, and maintains research and development programs focused on new therapies and technologies in its core fields.

In Pharmaceuticals, Bayer focuses on prescription drugs across therapeutic areas such as cardiology, oncology, hematology and women’s health, supporting clinical development and regulatory activities for both marketed products and pipeline candidates.